Novartis

Positive results from Novartis five-year VERIFY study in type 2 diabetes demonstrate long-term clinical benefits of early combination treatment with vildagliptin and metformin

Early combination treatment strategy with vildagliptin and metformin was superior to standard of care in newly diagnosed type 2 diabetes…

5 years ago

Novartis continues to build healthcare talent ecosystem; announces BioCamp 2019

BioCamp engages students around scientific advances to address unmet medical needs and entrepreneurial opportunities  Offers ~50 post-graduate students insights in…

5 years ago

Kuwait Pharmaceuticals Market Outlook to 2022: Ken Research

New Delhi, November 24, 2018: The report titled “Kuwait Pharmaceuticals Market Outlook to 2022 – By Type of Drugs (Generic…

5 years ago

GSK Consumer Healthcare appoints Filippo Lanzi as Head for Asia Pacific

Kolkata, January 17, 2018: GlaxoSmithKline (GSK) Consumer Healthcare has announced the appointment of Filippo Lanzi as Regional Head of Asia…

6 years ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420